Brokers Set Expectations for BIOX Q1 Earnings

Key Points

• Brookline Capital Management predicts that Bioceres Crop Solutions will report Q1 2026 earnings of ($0.03) per share, maintaining a "Hold" rating on the stock.
• Analyst estimates for the full year suggest expected earnings of ($0.05) per share, with forecasts indicating a range of quarterly earnings varying from $0.06 to ($0.07) per share in subsequent quarters.
• The stock of Bioceres Crop Solutions is currently trading at $2.06, with a consensus target price of $4.17 and a recent downgrade from Canaccord Genuity to a price target of $2.50.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Equities research analysts at Brookline Capital Management issued their Q1 2026 earnings per share estimates for shares of Bioceres Crop Solutions in a report released on Tuesday, September 9th. Brookline Capital Management analyst K. Dolliver anticipates that the company will post earnings per share of ($0.03) for the quarter. Brookline Capital Management has a "Hold" rating on the stock. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions' Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at ($0.07) EPS and Q4 2026 earnings at ($0.07) EPS.

Other equities research analysts have also recently issued reports about the company. Wall Street Zen cut Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a report on Saturday. Canaccord Genuity Group reissued a "hold" rating and set a $2.50 price target (down from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday, September 10th. Oppenheimer set a $5.00 price target on Bioceres Crop Solutions in a report on Tuesday, September 9th. Finally, Lake Street Capital decreased their price target on Bioceres Crop Solutions from $8.00 to $5.00 and set a "buy" rating on the stock in a report on Wednesday, September 10th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Bioceres Crop Solutions currently has a consensus rating of "Moderate Buy" and a consensus target price of $4.17.

Bioceres Crop Solutions Stock Performance

Bioceres Crop Solutions stock traded up $0.01 during trading on Thursday, reaching $1.96. The company had a trading volume of 205,701 shares, compared to its average volume of 246,229. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22. The firm's 50-day simple moving average is $3.21 and its 200 day simple moving average is $4.06. The firm has a market capitalization of $122.91 million, a price-to-earnings ratio of -2.40 and a beta of 0.43. Bioceres Crop Solutions has a 52 week low of $1.92 and a 52 week high of $8.79.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Fourth Sail Capital LP boosted its position in shares of Bioceres Crop Solutions by 25.1% during the first quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company's stock valued at $21,125,000 after buying an additional 928,708 shares during the period. Ardsley Advisory Partners LP boosted its position in shares of Bioceres Crop Solutions by 4.7% during the second quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company's stock valued at $4,441,000 after buying an additional 45,000 shares during the period. Long Focus Capital Management LLC boosted its position in shares of Bioceres Crop Solutions by 11.4% during the first quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company's stock valued at $3,788,000 after buying an additional 85,000 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Bioceres Crop Solutions by 9.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company's stock valued at $3,761,000 after buying an additional 71,581 shares during the period. Finally, Allianz Asset Management GmbH boosted its position in shares of Bioceres Crop Solutions by 77.5% during the first quarter. Allianz Asset Management GmbH now owns 236,717 shares of the company's stock valued at $1,081,000 after buying an additional 103,337 shares during the period. Hedge funds and other institutional investors own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.